Germain M A, Demers G, Mamelle G, Julieron M, Marandas P, Schwaab G, Luboinski B
Département de chirurgie cervicofaciale, institut Gustave-Roussy, Villejuif, France.
Chirurgie. 1999 Jun;124(3):272-82. doi: 10.1016/s0001-4001(99)80093-2.
Midface is situated between the occlusal plane and the transverse midorbital plane. The aim of midface reconstruction is to restore the bony and soft tissue contour of the face, to obtain a rigid support for the velum, to allow oronasal separation, and to allow support for the orbit and obliteration of the maxillary sinus in order to restore the main functions: respiration, speech, deglutition, mastication, olfaction, vision.
Between 1988 and 1997, 65 patients with defects to the midface in relation with cancer (n = 60), gunshot (n = 3), or congenital malformation (n = 2), underwent reconstruction with one or more transplants: forearm (n = 21), latissimus dorsi (n = 23), scapula (n = 12), composed subscapula (n = 10), and fibula (n = 4). Forty-seven of the patients were men and 18 were women. The mean age was 56 years (12-90 years). In patients with cancer, tumoral resection was immediately followed by midface reconstruction in the last 43 cases. Free flaps were selected for reconstruction of each part of the midface: cheek, nose, orbit floor, maxillary and palate.
One post-operative death occurred (1.5%). The morbidity rate (18.7%) included necrosis of the free flaps in four cases. Average resumption of oral intake was ten days. The mean time to discharge was 17 days. Aesthetic and functional results were rated good or excellent in 53 patients. After one year, 52 patients were alive. Oral intake was normal in 48 patients, and mixed in four. Speech was excellent or good in 49 patients. From amongst the patients, 80% were able to find a job.
Free flaps with micro surgery provides an optimal, functional, morphological and aesthetic outcome. Patients with advanced cancer of the midface are best managed through a multidisciplinary team approach. Microsurgical reconstruction represents the technical state of the art in case of extensive and complex midface defect.
面中部位于咬合平面与眶横中平面之间。面中部重建的目的是恢复面部的骨和软组织轮廓,为软腭获得坚固支撑,实现口鼻分离,并为眼眶提供支撑以及对上颌窦进行填塞,以恢复主要功能:呼吸、言语、吞咽、咀嚼、嗅觉、视觉。
1988年至1997年间,65例面中部有缺损的患者接受了一次或多次移植重建手术,这些缺损与癌症(60例)、枪伤(3例)或先天性畸形(2例)有关。所采用的移植组织包括:前臂(21例)、背阔肌(23例)、肩胛骨(12例)、组合肩胛下组织(10例)和腓骨(4例)。患者中男性47例,女性18例。平均年龄为56岁(12 - 90岁)。在癌症患者中,后43例患者在肿瘤切除后立即进行了面中部重建。针对面中部的各个部位(脸颊、鼻子、眶底、上颌和腭部)的重建均选择了游离皮瓣。
发生1例术后死亡(1.5%)。发病率为18.7%,包括4例游离皮瓣坏死。平均开始经口进食时间为10天。平均出院时间为17天。53例患者的美学和功能结果评定为良好或优秀。一年后,52例患者存活。48例患者经口进食正常,4例为混合性进食。49例患者言语功能优秀或良好。患者中80%能够找到工作。
显微外科游离皮瓣提供了最佳的功能、形态和美学效果。晚期面中部癌症患者最好通过多学科团队方法进行管理。对于广泛且复杂的面中部缺损,显微外科重建代表了当前的技术水平。